These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6522919)

  • 21. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.
    Mitchell SJ; Engelman J; Kent CK; Lukehart SA; Godornes C; Klausner JD
    Clin Infect Dis; 2006 Feb; 42(3):337-45. PubMed ID: 16392078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blinded, randomized, controlled clinical trial to compare cefazolin and cefonicid for antimicrobial prophylaxis in clean orthopedic surgery.
    Liebergall M; Mosheiff R; Rand N; Peyser A; Shaul J; Kahane Y; Shapiro M
    Isr J Med Sci; 1995 Jan; 31(1):62-4. PubMed ID: 7836052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in blood substitute research. Proceedings of an international symposium, San Francisco, California, September 29-October 1, 1982.
    Prog Clin Biol Res; 1983; 122():1-468. PubMed ID: 6878349
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of rifampin in the treatment of nontuberculous infections. Symposium held in San Francisco, California April 1982.
    Rev Infect Dis; 1983; 5 Suppl 3():S399-632. PubMed ID: 6635431
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings of the symposium on contemporary issues in Hodgkin's disease: biology, staging, and treatment (San Francisco, California, September 9--12, 1981).
    Cancer Treat Rep; 1982 Apr; 66(4):601-1067. PubMed ID: 7074632
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous immune globulin: its use and potential. Proceedings of a workshop. San Francisco, California, November 23, 1981.
    J Clin Immunol; 1982 Apr; 2(2 Suppl):1S-48S. PubMed ID: 7085860
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis in Mexican-born persons in San Francisco: reactivation, acquired infection and transmission.
    Jasmer RM; Ponce de Leon A; Hopewell PC; Alarcon RG; Moss AR; Paz EA; Schecter GF; Small PM
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):536-41. PubMed ID: 9487452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Academy of Neuropsychology Abstracts from the 21st Annual Meeting, San Francisco, California, October 31-November 3, 2001.
    Arch Clin Neuropsychol; 2001 Nov; 16(8):697-876. PubMed ID: 14589758
    [No Abstract]   [Full Text] [Related]  

  • 29. 36th annual scientific meeting of the Gerontological Society of America. November 18-22, 1983, San Francisco, California. Abstracts.
    Gerontologist; 1983 Oct; 23 Spec No():61-323. PubMed ID: 6642221
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B Today: New Guidelines for the Pediatrician. Proceedings of Symposium at the American Academy of Pediatrics Annual Meeting. San Francisco, California, October 15, 1992.
    Pediatr Infect Dis J; 1993 May; 12(5):425-53. PubMed ID: 8327311
    [No Abstract]   [Full Text] [Related]  

  • 31. Case study. Aggressive physician-led clinical reengineering helps University of California-San Francisco Medical Center stay competitive.
    Weber DO
    Strateg Healthc Excell; 1996 May; 9(5):1-10. PubMed ID: 10157255
    [No Abstract]   [Full Text] [Related]  

  • 32. External validation of the San Francisco Syncope Rule.
    Sun BC; Mangione CM; Merchant G; Weiss T; Shlamovitz GZ; Zargaraff G; Shiraga S; Hoffman JR; Mower WR
    Ann Emerg Med; 2007 Apr; 49(4):420-7, 427.e1-4. PubMed ID: 17210201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Mar; 53(9):197-8. PubMed ID: 15017376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2nd International Symposium on the Marfan Syndrome. Proceedings and abstracts. San Francisco, California, 7-9 November 1992.
    Am J Med Genet; 1993 Aug; 47(1):127-60. PubMed ID: 8103632
    [No Abstract]   [Full Text] [Related]  

  • 35. Delayed allergic reaction to cefonicid.
    Martin JA; Alonso MD; Lázaro M; Parra F; Compaired JA; Alvarez-Cuesta E
    Ann Allergy; 1994 Apr; 72(4):341-2. PubMed ID: 8154633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of high energy electrons in the treatment of cancer. 25th annual San Francisco Cancer Symposium. San Francisco, California, February 9-11, 1990.
    Front Radiat Ther Oncol; 1991; 25():1-333. PubMed ID: 1874452
    [No Abstract]   [Full Text] [Related]  

  • 37. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic impact of cefonicid. A symposium, San Francisco, California, November 18-19, 1982.
    Rev Infect Dis; 1984; 6 Suppl 4():S777-937. PubMed ID: 6522919
    [No Abstract]   [Full Text] [Related]  

  • 40. Cefonicid sodium (Monocid).
    Med Lett Drugs Ther; 1984 Aug; 26(667):71-2. PubMed ID: 6379400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.